Wegovy Side Effects: What to Expect, Timeline and How to Manage Them

Last reviewed: April 2026

Wegovy side effects are the number one concern for Canadians starting semaglutide 2.4 mg for weight loss. Most people will experience at least one side effect during treatment, with nausea, diarrhea, and vomiting topping the list. The good news? The majority of these side effects are mild to moderate, peak during the dose escalation phase, and improve as your body adjusts. In this article, we break down every known Wegovy side effect by frequency, walk you through a week-by-week timeline of what to expect at each dose, and share practical management tips backed by clinical trial data.

What Is Wegovy and Why Do Side Effects Happen?

Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist approved by Health Canada for chronic weight management. It works by mimicking a natural hormone called glucagon-like peptide-1, which slows gastric emptying, reduces appetite, and signals your brain that you are full.

Side effects mainly occur because of how the drug interacts with your gastrointestinal (GI) system. GLP-1 receptors line your stomach and intestines. When semaglutide activates them, your stomach empties more slowly than usual. That delayed emptying is what causes the nausea, bloating, and other GI symptoms most people notice in the first weeks.

Prescribing information from Novo Nordisk confirms that GI events are the most frequently reported adverse reactions. In the STEP 1 clinical trial, roughly 74% of participants taking Wegovy reported at least one GI side effect compared to 47% in the placebo group.

If you are still deciding whether to start treatment, our Wegovy guide covers eligibility, dosing, and what to discuss with your doctor.

Common Wegovy Side Effects

These data come from the STEP clinical trial program, which enrolled over 4,500 participants across multiple studies.

Common Side Effects with Frequency Percentages

| Side Effect | Wegovy (%) | Placebo (%) | Notes |

|---|---|---|---|

| Nausea | 44% | 18% | Most common, usually mild |

| Diarrhea | 30% | 16% | Often intermittent |

| Vomiting | 24% | 6% | More likely during dose increases |

| Constipation | 24% | 10% | Can persist throughout treatment |

| Abdominal pain | 20% | 11% | Usually upper abdomen |

| Headache | 14% | 13% | Similar to placebo rates |

| Fatigue | 11% | 5% | Tends to improve over time |

| Dyspepsia (indigestion) | 9% | 4% | Burning or discomfort after eating |

| Dizziness | 8% | 4% | Typically mild |

| Bloating/gas | 7% | 4% | Related to slowed gastric emptying |

| Gastroesophageal reflux | 7% | 2% | May worsen existing GERD |

| Eructation (belching) | 5% | 1% | Often temporary |

| Injection site reactions | 4% | 2% | Redness, itching, bruising |

Although 44% of participants reported nausea, the vast majority described it as mild to moderate. Only about 3–4% discontinued Wegovy specifically because of nausea, suggesting most people find it manageable.

Nausea: The Side Effect Everyone Asks About

Nausea is the most talked-about Wegovy side effect. Almost half of all users experience it at some point. For most people, it:

• Appears in the first few days after starting a new dose

• Peaks over several days, then fades over 1–3 weeks

• Is worse with large, heavy, or fatty meals

• Often returns briefly each time you move up to the next dose during titration

Gastrointestinal Side Effects Beyond Nausea

Diarrhea and constipation are both common, and some people alternate between the two. Semaglutide changes gut motility in ways that vary from person to person.

Vomiting is more concerning when it is persistent. In trials, most vomiting episodes were isolated and tied to eating too much or too quickly after a dose increase. Persistent vomiting lasting more than 48 hours should prompt a call to your healthcare provider.

Serious and Rare Wegovy Side Effects

Most Wegovy side effects are GI-related and temporary, but some serious adverse events require prompt medical attention.

Serious and Rare Side Effects

| Side Effect | Estimated Frequency | Severity | Action Required |

|---|---|---|---|

| Pancreatitis | Rare (<1%) | Serious | Seek emergency care for severe, persistent abdominal pain radiating to the back |

| Gallbladder disease (gallstones, cholecystitis) | 1.6% vs 0.7% placebo | Serious | Report upper right abdominal pain, especially after meals |

| Acute kidney injury | Rare | Serious | Report significantly decreased urination or swelling |

| Allergic reactions (anaphylaxis, angioedema) | Very rare | Potentially life-threatening | Call 911 for trouble breathing, swelling of face/throat |

| Increased heart rate | 1–4 bpm average increase | Mild to moderate | Monitor; report sustained increases over 20 bpm |

| Thyroid C-cell tumors (medullary thyroid carcinoma) | Observed in rodents only | Boxed warning | Report neck mass, difficulty swallowing, persistent hoarseness |

| Suicidal ideation | Under active investigation | Serious | Report any new mood changes to your doctor immediately |

| Hypoglycemia (with insulin or sulfonylureas) | Uncommon alone, higher with combo therapy | Moderate to serious | Diabetes meds may need adjustment |

| Diabetic retinopathy complications | Rare, mainly in type 2 diabetes | Serious | Diabetic patients need regular eye exams |

The Thyroid Cancer Boxed Warning

Wegovy carries a boxed warning about thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on rat studies. There is no confirmed link in humans, but Wegovy is contraindicated if you have:

• A personal or family history of MTC, or

• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Tell your prescriber if anyone in your family has had thyroid cancer.

Gallbladder Issues

Rapid weight loss increases gallstone risk, and semaglutide adds to that baseline risk. In STEP 1, cholelithiasis and cholecystitis occurred at roughly double the rate in the Wegovy group vs placebo.

Contact your doctor if you notice:

• Sharp upper right abdominal pain, especially after fatty meals

• Pain with fever, nausea, or vomiting

Mental Health and Suicidal Ideation

Health Canada and the EMA have been investigating reports of suicidal thoughts with GLP-1 receptor agonists. As of early 2026, no definitive causal link has been proven, but monitoring continues.

If you experience new or worsening depression, anxiety, or thoughts of self-harm while taking Wegovy, seek medical advice immediately.

Wegovy Side Effects Timeline by Dose

Wegovy uses a 16-week dose escalation to minimize side effects, gradually increasing to the 2.4 mg maintenance dose.

Side Effects by Titration Dose Timeline

| Weeks | Dose | Common Side Effects at This Stage | What Patients Report |

|---|---|---|---|

| Weeks 1–4 | 0.25 mg | Mild nausea, decreased appetite, occasional headache | "I barely notice anything" to "mild queasiness after dinner" |

| Weeks 5–8 | 0.5 mg | Slightly more nausea, some diarrhea or constipation, fatigue | "Appetite is noticeably reduced, some stomach gurgling" |

| Weeks 9–12 | 1.0 mg | Nausea peaks for many, vomiting possible, abdominal discomfort, bloating | "This was the hardest dose jump for me" |

| Weeks 13–16 | 1.7 mg | GI symptoms may flare again, heartburn/reflux, continued appetite suppression | "Nausea came back for a week then settled" |

| Week 17+ | 2.4 mg (maintenance) | Symptoms usually stabilize; some ongoing constipation, occasional nausea | "My body finally adjusted. I still eat smaller meals." |

The 1.0 mg step (weeks 9–12) is often the toughest. If side effects are not tolerable, your prescriber can:

• Keep you at the current dose for an extra 4 weeks, or

• Step you back down to the previous dose for a few weeks before retrying the titration.

• Prescribe an antiemetic (anti-nausea medication) to bridge the worst week.

How to Manage Wegovy Side Effects

Most Wegovy side effects respond well to small lifestyle adjustments. The tips below come from prescriber recommendations and patient feedback gathered across the STEP trial program and clinical practice.

For Nausea

Eat smaller, more frequent meals. Skip greasy, fried, or very sweet foods during the first week of each new dose. Ginger tea or ginger candies help many patients. Some find that taking the injection in the evening (instead of the morning) reduces daytime nausea. Stay hydrated with water or electrolyte drinks throughout the day.

For Constipation

Increase water intake to 2 to 3 litres per day. Add fibre-rich foods (vegetables, beans, oats) gradually. A daily fibre supplement such as psyllium husk can help if dietary changes are not enough. Light daily exercise like walking stimulates bowel movements. If constipation persists more than a week, your pharmacist can recommend an over-the-counter laxative.

For Diarrhea

Stay hydrated with electrolyte drinks (such as Pedialyte or LiquidIV). Avoid dairy and high-fat foods temporarily. Choose easy-to-digest options like brothy soups, oatmeal, boiled potatoes, and gentle proteins such as eggs, chicken, and fish to keep nutrients up while your stomach settles. Diarrhea usually resolves within 1 to 2 weeks. If it lasts longer or includes blood or fever, contact your prescriber.

For Heartburn or Reflux

Eat slower and stop earlier than usual at meals. Wegovy slows gastric emptying, so even small portions can feel heavy. Avoid lying down for 2 hours after eating. Over-the-counter antacids or H2 blockers (such as famotidine) help during the first weeks. If reflux is severe or persistent, your prescriber may add a proton pump inhibitor.

For Injection Site Reactions

Rotate injection sites between abdomen, thigh, and upper arm with each weekly dose. Let the pen come to room temperature for 15 to 30 minutes before injecting (this reduces stinging). Clean the area with alcohol and let it dry completely before injecting. Mild redness, itching, or bruising at the site is common and usually fades within a few days.

When to Call Your Doctor or Go to the ER

Most Wegovy side effects are manageable at home, but a few signs warrant prompt medical attention. Contact your prescriber, call 811 (Canadian health line), or go to urgent care if you experience any of the following:

• Severe abdominal pain that does not go away (especially pain radiating to the back, which can signal pancreatitis)

• Persistent vomiting (unable to keep fluids down for 24 to 48 hours)

• Sharp upper-right abdominal pain after fatty meals (possible gallstone)

• Yellowing of skin or eyes (jaundice), which can signal a gallbladder or liver issue

• Signs of allergic reaction (swelling of face, tongue, or throat; difficulty breathing) — call 911 immediately

• A new lump or swelling in your neck, hoarseness, or difficulty swallowing (possible thyroid concern)

• Significant decrease in urine output, swelling of the legs, or extreme fatigue (possible kidney concern)

• New or worsening depression, anxiety, or thoughts of self-harm

Online Providers Cost Comparison

Managing Wegovy side effects safely starts with a qualified prescriber and reliable clinical follow-up during titration. Below is how the main Canadian online providers compare for Wegovy prescribing and ongoing care, with MyRocky now our highest-rated GLP-1 provider overall.

Generic semaglutide is now also available in-person at Canadian pharmacies including Shoppers Drug Mart, Rexall, Costco, and Walmart, typically priced at $85 to $120 per month depending on the pharmacy — with Costco usually lowest. That makes the in-person retail route generally cheaper than telehealth providers like Felix Health, which charges $149 per month for the same generic.

MyRocky is our highest-rated Canadian GLP-1 telehealth provider in 2026 (9.4/10). MyRocky operates its own LegitScript-certified pharmacy in Mississauga, employs Canadian-licensed MDs, nurse practitioners and pharmacists, and serves all 10 provinces (including Quebec and New Brunswick where Felix and Hims do not). The $99 one-time consultation includes lab work and the first prescription, with a 4-week monitoring cadence to catch and manage side effects early. Read our full MyRocky review.

Frequently Asked Questions

How long do Wegovy side effects last?

Most common side effects (nausea, diarrhea, abdominal pain) peak within the first 1 to 2 weeks of each new dose and improve substantially by week 4 to 6. By the time most patients reach the 2.4 mg maintenance dose around week 17, GI side effects have either resolved or become very mild. Some patients continue to experience occasional constipation or reduced appetite long-term, which is partly the desired therapeutic effect.

Does Wegovy cause hair loss?

Hair shedding is reported by some Wegovy users, though it is not listed as a common side effect in the prescribing information. The likely cause is the rapid weight loss itself (a known trigger for telogen effluvium) and reduced food intake during the first months. Adequate protein (1.2 to 1.6 g/kg body weight per day), iron, zinc, and biotin help. Hair typically regrows within 6 to 12 months once weight stabilizes.

Can I drink alcohol while taking Wegovy?

Alcohol is not strictly contraindicated with Wegovy, but most patients find their tolerance drops sharply. Alcohol can worsen nausea, GI side effects, and dehydration. It also adds calories without satiety, which can blunt weight-loss results. Most prescribers recommend limiting alcohol or skipping it entirely during titration.

What is Wegovy face?

"Wegovy face" (also called "Ozempic face") refers to the gaunt, aged appearance some patients develop after rapid weight loss. It is caused by fat loss in the cheeks and temples that makes skin sag. It is not unique to Wegovy and occurs with any rapid weight loss method. Slowing the titration pace, prioritizing protein, and resistance training help preserve facial muscle and reduce the effect.

How are Wegovy side effects different from Ozempic?

Wegovy and Ozempic contain the same active ingredient (semaglutide), but Wegovy is dosed higher (2.4 mg maintenance vs Ozempic's 1 mg or 2 mg). The higher dose means Wegovy patients experience GI side effects more often and more intensely. Nausea was reported in 44% of Wegovy STEP 1 participants vs about 20% in Ozempic SUSTAIN trials. The side effect categories are the same; the rates are higher with Wegovy.

Should I stop taking Wegovy if I have side effects?

Mild to moderate side effects are expected during titration and usually settle. Do not stop Wegovy on your own without talking to your prescriber. If side effects are intolerable, your prescriber can pause the titration, step you down to the previous dose, or prescribe medications to bridge the worst week. Stop and seek medical attention immediately for severe abdominal pain, signs of allergic reaction, or persistent vomiting.

Sources

• Novo Nordisk Canada Wegovy Product Monograph. Novo Nordisk Canada. Health Canada-approved product information including full adverse reaction profile.

• STEP 1 Clinical Trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine (Wilding et al., 2021). Primary safety and efficacy data for Wegovy.

• Health Canada Adverse Reaction Database (Canada Vigilance). Government of Canada. Post-market safety reports for semaglutide products in Canada.

• Obesity Canada Clinical Practice Guidelines. Obesity Canada. GLP-1 medication management and side-effect mitigation guidance.